Co-ordinate expression of activin A and its type I receptor mRNAs during phorbol ester-induced differentiation of human K562 erythroleukemia cells

Molecular and Cellular Endocrinology

Volumn 153, Issue 1-2, 1999, Pages 137-145

  Hilden K ^a   Tuuri, T ^a   Eramaa M ^a   Ritvos, O ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Activin; Activin receptor; cAMP; Human erythroleukemia K562 cells; TPA

Indexed keywords

ACTIVIN A; ACTIVIN RECEPTOR; MESSENGER RNA; PHORBOL ESTER;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; ERYTHROLEUKEMIA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MEGAKARYOPOIESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR UPREGULATION; RNA ANALYSIS; SIGNAL TRANSDUCTION;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ACTIVIN RECEPTORS; ACTIVINS; BLOTTING, SOUTHERN; CELL DIFFERENTIATION; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DIMERIZATION; DRUG SYNERGISM; ENZYME ACTIVATION; GENE EXPRESSION; HUMANS; INHIBINS; K562 CELLS; MEGAKARYOCYTES; RECEPTORS, GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033587564     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(99)00074-X     Document Type: Article

References (48)

1. Alitalo R., Mäkelä T.P., Koskinen P., Andersson L.C., Alitalo K. Enhanced expression of transforming growth factor β during megakaryoblastic differentiation of K562 leukemia cells. Blood. 71:1988;899-906.
2. Attisano L., Cárcamo J., Ventura F., Weis F.M.B., Massagué J., Wrana J.L. Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors. Cell. 75:1993;671-680.
3. Attisano L., Wrana J.L., Montalvo E., Massagué J. Activation of signalling by the activin receptor complex. Mol. Cell. Biol. 16:1996;1066-1073.
4. Broxmeyer H.E., Lu L., Cooper S., Schwall R.H., Mason A.J., Nikolics K. Selective and indirect modulation of human multipotential and erythroid hematopoietic progenitor cell proliferation by recombinant human activin and inhibin. Proc. Natl. Acad. Sci. USA. 85:1988;9052-9056.
5. Campen C.A., Vale W. Characterization of activin A binding sites on the human leukemia cell line K562. Biochem. Biophys. Res. Commun. 157:1988;844-849.
6. Cárcamo J., Weis F.M.B., Ventura F., Wieser R., Wrana J.L., Attisano L., Massagué J. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor β and activin. Mol. Cell. Biol. 14:1994;3810-3821.
7. Chirgwin J.M., Przybyla A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
8. Chomczynski P. One-hour downward alkaline capillary transfer for blotting of DNA and RNA. Anal. Biochem. 201:1992;134-139.
9. Davis S.R., Krozowski Z., McLachlan R.I., Burger H.G. Inhibin gene expression in the human corpus luteum. J. Endocrinol. 115:1987;R21-R23.
10. Erämaa M., Heikinheimo K., Tuuri T., Hildén K., Ritvos O. Inhibin/activin subunit mRNA expression in human granulosa-luteal cells. Mol. Cell. Endocrinol. 92:1993;R15-R20.
11. Erämaa M., Hildén K., Tuuri T., Ritvos O. Regulation of inhibin/activin subunit messenger ribonucleic acids (mRNAs) by activin A and expression of activin receptor mRNAs in cultured human granulosa-luteal cells. Endocrinology. 136:1995;4382-4389.
12. Erämaa M., Hurme M., Stenman U.H., Ritvos O. Activin A/erythroid differentiation factor is induced during human monocyte activation. J. Exp. Med. 176:1992;1449-1452.
13. Eto Y., Tsuji T., Takezawa M., Takano S., Yokogawa Y., Shibai H. Purification and characterization of erythroid differentiation factor (EDF) isolated from human leukemia cell line THP-1. Biochem. Biophys. Res. Commun. 142:1987;1095-1103.
14. Fang J., Yin W., Smiley E., Wang S.Q., Bonadio J. Molecular cloning of the mouse activin βE subunit gene. Biochem. Biophys. Res. Commun. 228:1996;669-674.
15. Hildén K., Tuuri T., Erämaa M., Ritvos O. Expression of type II activin receptor genes during differentation of human K562 cells and cDNA cloning of the human type IIB activin receptor. Blood. 83:1994;2163-2170.
16. Hino M., Tojo A., Miyazono K., Miura Y., Chiba S., Eto Y., Shibai H., Takaku F. Characterization of cellular receptors for erythroid differentiation factor on murine erythroleukemia cells. J. Biol. Chem. 264:1989;10309-10314.
17. Hötten G., Neidhardt H., Schneider C., Pohl J. Cloning of a new member of the TGF-β family: A putative new activin βC-chain. Biochem. Biophys. Res. Commun. 206:1995;608-613.
18. Li W., Olofsson J.I., Jeung E.-B., Krisinger J., Yeun B.H., Leung P.C.K. Gonadotropin-releasing hormone (GnRH) and cyclic AMP positively regulate inhibin subunit messenger RNA levels in human placental cells. Life Sci. 55:1994;1717-1724.
19. Mason A.J., Hayflick J.S., Ling N., Esch F., Ueno N., Ying S.-Y., Guillemin R., Niall H., Seeburg P.H. Complementary cDNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta. Nature. 318:1985;659-663.
20. Mason A.J., Niall H.D., Seeburg P.H. Structure of two human ovarian inhibins. Biochem. Biophys. Res. Commun. 135:1986;957-964.
21. Mathews L. Activin receptors and cellular signaling by the receptor serine kinase family. Endocr. Rev. 15:1994;310-325.
22. Murata M., Eto E., Shibai H., Sakai M., Muramatsu M. Erythroid differentiation factor is encoded by the same mRNA as that of the inhibin βA chain. Proc. Natl. Acad. Sci. USA. 85:1988;2434-2438.
23. Murray N.R., Baumgardner G.P., Burns D.J., Fields A.P. Protein kinase C isotypes in human erythroleukemia (K562) cell proliferation and differentiation. J. Biol. Chem. 268:1993;15847-15853.
24. Nakao K., Kosaka M., Saito S. Effects of erythroid differentiation factor (EDF) on proliferation and differentiation of human hematopoietic progenitors. Exp. Hematol. 19:1991;1090-1095.
25. Rappolee D.A., Wang A., Mark D., Werb Z. Novel method for studying mRNA phenotypes in single or small numbers of cells. J. Cell. Biochem. 39:1989;1-11.
26. Ritvos O., Erämaa M. Adenosine 3′,5′ monophosphate and phorbol ester induce transforming growth factor-β1 messenger ribonucleic acid levels in choriocarcinoma cells. Endocrinology. 129:1991;2240-2245.
27. Ritvos O., Tuuri T., Erämaa M., Sainio K., Hildén K., Saxén L., Gilbert S.F. Activin disrupts epithelial branching morphogenesis in developing glandular organs of the mouse. Mech. Dev. 50:1995;229-245.
28. Schwall R., Schmelzer C.H., Matsuyama E., Mason A.J. Multiple actions of recombinant activin-A in vivo. Endocrinology. 125:1989;1420-1423.
29. Schwall R.H., Nikolics K., Szonyi E., Gorman C., Mason A.J. Recombinant expression and characterization of human activin A. Mol. Endocrinol. 2:1988;1237-1242.
30. Shimonaka M., Inouye S., Shimasaki S., Ling N. Follistatin binds to both activin and inhibin through the common beta-subunit. Endocrinology. 128:1991;3313-3315.
31. Shiozaki M., Sakai R., Tabuchi M., Eto Y., Kosaka M., Shibai H. In vivo treatment with erythroid differentiation factor (EDF/activin A) increases erythroid precursors (CFU-E and BFU-E) in mice. Biochem. Biophys. Res. Commun. 165:1989;1155-1161.
32. Stewart A.G., Milborrow H.M., Ring J.M., Crowther C.E., Forage R.G. Human inhibin genes: genomic characterization and sequencing. FEBS Lett. 206:1986;329-334.
33. Tabilio A., Pelicci P.G., Vinci G., Mannoni P., Cicin C.I., Vainchenker W., Testa U., Lipinski M., Rochant H., Bretin-Gorius J. Myeloid and megakaryocytic properties of K562 cell lines. Cancer. Res. 43:1983;4569-4574.
34. Takahashi S., Yamashita T., Eto Y., Shibai H., Miyamoto K., Ogata E. Inducible gene expression of activin A/erythroid differentation factor in HL-60 cells. Biochem. Biophys. Res. Commun. 167:1990;654-658.
35. Tanimoto K., Murakami K., Fukamizu A. Possible role of the 3′-flanking sequences of the human activin βA subunit gene in its expression. Arch. Biochem. Biophys. 302:1993;409-416.
36. Tanimoto K., Murakami K., Fukamizu A. Combinatorial action of cAMP and phorbol ester on synergistic expression of the human activin A gene. Exp. Cell. Res. 211:1994;408-414.
37. Tanimoto K., Yoshida E., Mita S., Nibu Y., Murakami K., Fukamizu A. Human activin βA gene. Identification of novel 5′ exon, functional promoter and enhancers. J. Biol. Chem. 271:1996;32760-32769.
38. ten Dijke P., Ichijo H., Franzén P., Schultz P., Saras J., Toyoshima H., Heldin C.-H., Miyazono K. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene. 8:1993;2879-2887.
39. ten Dijke P., Yamashita H., Ichijo H., Franzén P., Laiho M., Miyazono K., Heldin C.-H. Characterization of type I receptors for transforming growth factor-β and activin. Science. 264:1994;101-104.
40. Thomas P.S. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA. 77:1980;5201-5205.
41. Tsuchida K., Vaughan J.M., Wiater E., Gaddy-Kurten D., Vale W.W. Inactivation of activin-dependent transcription by kinase-deficient activin receptors. Endocrinology. 136:1995;5493-5503.
42. Tsuji T., Eto Y., Takano S., Takezawa M., Yokogawa Y., Shibai H. Discovery of a human erythroid differentiation factor (EDF) and its large-scale production. Biotech. Bioengin. 31:1988;675-681.
43. Tuuri T., Erämaa M., Hilden K., Ritvos O. The tissue distribution of activin βA- and βB-subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. J. Clin. Endocrinol. Metab. 78:1994;1521-1524.
44. Tuuri T., Erämaa M., van Schaik R.H.N., Ritvos O. Differential regulation of inhibin/activin α- and βA- subunit and follistatin mRNAs by cyclic AMP and phorbol ester in cultured human granulosa-luteal cells. Mol. Cell. Endocrinol. 121:1996;1-10.
45. Vale W., Hsueh A., Rivier C., Yu J. The inhibin/activin family of hormones and growth factors. Spornand M.B., Roberts A.B. Peptide Growth Factors and Their Receptors II. 1990;211-248 Springer, New York.
46. Voutilainen R., Erämaa M., Ritvos O. Hormonally regulated inhibin gene expression in human fetal and adult adrenals. J. Clin. Endocrinol. Metab. 73:1991;1026-1030.
47. Yamashita T., Takahashi S., Ogata E. Expression of activin A/erythroid differentation factor in murine bone marrow stromal cells. Blood. 79:1992;304-307.
48. Yu J., Shao L., Lemas V., Yu A., Vaughan J., Rivier J., Vale W. Importance of FSH-releasing protein and inhibin in erythrodifferentiation. Nature. 330:1987;765-767.